Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Hester Biosciences submits financial results

31 Jul 2019

Hester Biosciences has informed about submission of Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019. 

The above information is a part of company’s filings submitted to BSE.

Related Hester Biosciences Ltd. Links:

Hester Biosciences Share Price

2566.85 -53.30 (-2.03%) Jun 23, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 665.15
Dr. Reddys Lab 5299.75
Lupin 1154.40
Piramal Enterprises 2432.55
Cadila Healthcare 624.35
View more..
Sensex vs Hester Biosciences
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback